Category Archives: Transhuman News

Thames Kosmos Biology Genetics and DNA
Special Price Link: http://www.demizzy.com Isolate the DNA from a tomato Learn about inheritance and how traits are expressed Build a DNA model Breed bacteria to experiment with genetic engineering Best Seller In depth investigation of genetics and DNA. Isolate the DNA from a tomato. learn about inheritance and how traits are expressed. build a DNA model. breed bacteria to experiment with genetic engineering. The full-color. 48-page manual guides your experiments.From:HeidiDAlvarezRViews:0 0ratingsTime:00:50More inPeople Blogs

Read more:
Thames

Dr Richard Thompson: Genetic engineering and the Vedas
Sadaputa das or Dr RT was the forerunner of the extensive research and study of the Vedic Cosmology,he refuted the big bang theory as well as the theory of evolution of speisces.From:Saree3Views:11 0ratingsTime:31:42More inHowto Style

Link:
Dr Richard Thompson: Genetic engineering and the Vedas - Video

Romani, France, Cannabis, California, and Genetic Engineering. Oh my!
Just me, doing what I do.From:GothRevolutionaryViews:0 0ratingsTime:12:18More inPeople Blogs

Original post:
Romani, France, Cannabis, California, and Genetic Engineering. Oh my! - Video

genetic engineering book review
From:SeeSparkyPlayViews:0 0ratingsTime:02:51More inEducation

Excerpt from:
genetic engineering book review - Video

Team Bee: TMC. ICTD Spring 2012
An experiment in genetic engineering turns harmless sheep into blood-thirsty killers that terrorize a sprawling New Zealand farm. ...while, a very similar plotline to our subject, not entirely accurate, as there was robots and programming involved. Just ask Daniel, he touched them.From:drewworksViews:26 3ratingsTime:03:33More inEducation

More here:
Team Bee: TMC. ICTD Spring 2012 - Video

Public release date: 8-Nov-2012 [ | E-mail | Share ]

Contact: Vicki Cohn vcohn@liebertpub.com 914-740-2100 x2156 Mary Ann Liebert, Inc./Genetic Engineering News

New Rochelle, NY, November 8, 2012Concussion is a common disorder estimated to affect no fewer than 1.7-3.8 million people in the U.S. each year. Many more people with concussion likely do not seek medical care for symptoms of concussion and may suffer long-lasting, progressive, and profoundcognitive, psychiatric, and neurologic effects. The first use of teleconcussion, a novel solution for management and follow-up of a concussed athlete with remote access technology, is described in an article published in Telemedicine and e-Health, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers (http://www.liebertpub.com). The article is available free on the Telemedicine and e-Health website (http://www.liebertpub.com/tmj).

In the article "Teleconcussion: An Innovative Approach to Screening, Diagnosis, and Management of Mild Traumatic Brain Injury,"(http://online.liebertpub.com/doi/full/10.1089/tmj.2012.0118) Bert Vargas, MD and colleagues, Mayo Clinic Arizona--Neurology (Phoenix), present a case study in which telemedicine is used to assess and manage a high school athlete who had begun to resume physical activity following a concussion, in advance of accepted return-to-play guidelines. As in many states, Arizona law mandates that players of interscholastic sports removed from competitions for suspicion of having a concussion require formal clearance by a specially trained healthcare provider before returning to play. The use of telemedicine networks to facilitate timely access to subspecialty care can help ensure the health and safety of rural student-athletes.

"The ability to identify a mild traumatic brain injury (TBI) soon after it is sustained, whether on the battlefield or the sports field, is of great importance and high utility," says Charles R. Doarn, MBA, one of the Editors-in-Chief of the Journal and Research Professor of Family and Community Medicine, University of Cincinnati, Ohio. "The integration of 'teleconcussion' and Vargas et al.'s work can add great value to this very important field."

###

About the Journal

Telemedicine and e-Health (http://www.liebertpub.com/tmj) is an Official Journal of the American Telemedicine Association, the Canadian Telehealth Forum of COACH, and the International Society for Telemedicine and eHealth. Edited by Ronald C. Merrell, MD, Professor of Surgery, Virginia Commonwealth University, Richmond, and Charles Doarn, MBA, Department of Public Health Sciences, University of Cincinnati, Telemedicine and e-Health is the leading international, peer-reviewed journal combining medicine, telecommunications, and information technology. Published 10 times a year in print and online, the Journal covers telemedicine applications that are playing an increasingly important role in health care and provides tools that are indispensable for home health care, remote patient monitoring, and disease management. It encompasses not only rural health and battlefield care, but nursing homes, assisted living facilities, and maritime and aviation applications. Tables of content and a free sample issue may be viewed on the Telemedicine and e-Health website (http://www.liebertpub.com/tmj).

About the Publisher

Mary Ann Liebert, Inc., publishers (http://www.liebertpub.com) is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Population Health Management, Games for Health Journal, and Journal of Laparoendoscopic Surgery and Advanced Surgical Techniques. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 70 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website (http://www.liebertpub.com).

View post:
Teleconcussion--A new, innovative strategy for assessing young athletes

Genetic Engineering Ethics
A video we made for our grade 12 ethical issues project. Enjoy :)From:IvanaLucijaViews:1 0ratingsTime:03:27More inEducation

See the article here:
Genetic Engineering Ethics - Video

BANGALORE, November 9, 2012 /PRNewswire/ --

DNA Gene Therapy for Degenerative Diseases

In todays reality, terms like genetic engineering and gene therapy have become facts which prophets of science had only dreamt about few years ago. Pain, disability and disease have long plagued mankind, medicine has long sought its answers, research and development are yet uncovering labyrinths of technology to reach to a panacea.

Dr.Agarwal Hospitals nestled in bubbling Bangalore has brought out a customized version of GENE THERAPY where the patients own peripheral capillary blood (one drop) is taken as the raw stock admixed with Mana (DNA activator) it brings back healthy or fetal DNA of the same patient. This is then used as injections to the same patient within seconds of the mixture. A course of ten injections is given over a span of one week to ten days bringing about a healthy change in the patients course of disease.

Over 20 years of research conducted by Dr.Agarwal Hospitals on genetic engineering, where last 8 years have been spent on treating over 12000 patients through variety of illness in different stages of disease has brought new hope to mankind.

Mana (DNA activator) a propriety formula is taken in a syringe and customized with a drop of the patients blood. This forms the patients healthy DNA in vitro and is given back to the patient as sub cutaneous injections over a period of ten days every month for severe conditions.

Mana is a DNA activator - proven to recreate patients own healthy DNA

When Mana & Plasma are mixed within the first second healthy DNA strands start amplifying (proven through research and validation)

Its the patients own DNA being given back : No Side Effects

Dr.Sunita Rana Agarwal, Chief Scientist, Dr Agarwal Hospitals & Gene Research Foundation, carried out the research in this field on patients who were HIV positive. The CD4 ratio counts varied from 186 to 358 from 2004. In 90% of the patients CD4 ratio has increased to above 500 cells per micro liter.

See the article here:
New Ray of Hope for HIV Patients